CEMP

Cempra (CEMP)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CEMP
DataOraFonteTitoloSimboloCompagnia
03/08/202014:00GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive OfficerNASDAQ:CEMPCempra
07/02/201812:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CEMPCempra
26/01/201822:47Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CEMPCempra
22/01/201823:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CEMPCempra
19/01/201823:17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:CEMPCempra
12/01/201819:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CEMPCempra
11/01/201823:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CEMPCempra
11/01/201823:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CEMPCempra
10/01/201812:12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CEMPCempra
10/01/201800:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CEMPCempra
09/01/201822:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CEMPCempra
08/01/201823:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CEMPCempra
05/12/201723:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CEMPCempra
04/12/201714:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CEMPCempra
16/11/201722:35Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)NASDAQ:CEMPCempra
13/11/201723:11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CEMPCempra
13/11/201722:39Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CEMPCempra
03/11/201716:59GlobeNewswire Inc.Cempra Announces Preliminary Results of 2017 Stockholder Vote NASDAQ:CEMPCempra
02/11/201721:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CEMPCempra
01/11/201712:00GlobeNewswire Inc.Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined OrganizationNASDAQ:CEMPCempra
31/10/201712:00GlobeNewswire Inc.Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined CompanyNASDAQ:CEMPCempra
24/10/201714:00GlobeNewswire Inc.Melinta Therapeutics Publication Reinforces Baxdela Tolerability and Activity in Patients with MRSA Infections and Challengin...NASDAQ:CEMPCempra
10/10/201714:00GlobeNewswire Inc.Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of AcneNASDAQ:CEMPCempra
05/10/201712:11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CEMPCempra
04/10/201719:14GlobeNewswire Inc.Melinta Therapeutics Presents Outcomes of Baxdela Treatment of Gram-Positive and Gram-Negative Pathogens at IDWeekNASDAQ:CEMPCempra
28/09/201722:15GlobeNewswire Inc.Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed MergerNASDAQ:CEMPCempra
25/09/201714:00GlobeNewswire Inc.Melinta Therapeutics Presenting Detailed Analyses from Baxdela Phase 3 ABSSSI Trials and In Vitro Performance against Isolate...NASDAQ:CEMPCempra
10/09/201714:45PR Newswire (US)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cempra, Inc. -- CEMPNASDAQ:CEMPCempra
07/09/201722:15GlobeNewswire Inc.Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process UpdateNASDAQ:CEMPCempra
07/09/201712:05Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CEMPCempra
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CEMP
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network